EVALUATION AND OUTCOMES OF MIDODRINE, OCTREOTIDE, AND ALBUMIN IN PATIENTS WITH HEPATORENAL SYNDROME

被引：0
|
作者：
Patel, Jignesh [1 ]
Tran, Michelle [2 ]
Trujillo, Nalea [3 ]
Mata, Kenneth [4 ]
Chan, Patrick [1 ]
机构：
[1] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA
[2] Univ Calif Irvine, Med Ctr, Irvine, CA USA
[3] Stanford Hlth Care, Newark, CA USA
[4] Kaiser Permanente Med Ctr, Los Angeles, CA USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
950
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TERLIPRESSIN IS ASSOCIATED WITH DECREASED HEALTHCARE RESOURCE UTILIZATION COMPARED WITH MIDODRINE/ OCTREOTIDE AMONG PATIENTS WITH HEPATORENAL SYNDROME
    DeSousa, Alexandra
    Goyal, Tanvi
    Kaplan, David
    Nahas, Jonathan
    HEPATOLOGY, 2024, 80
  • [22] OCTREOTIDE, MIDODRINE, AND ALBUMIN TRIPLE THERAPY DOES NOT INFLUENCE POST-LIVER TRANSPLANT RENAL OUTCOMES IN PATIENTS WITH NEPATORENAL SYNDROME
    Rice, John P.
    Skagen, Catherine
    Said, Adnan
    HEPATOLOGY, 2010, 52 (04) : 858A - 858A
  • [23] Treatment With Albumin, Octreotide and Midodrine Is Effective as a Bridge to Liver Transplant in Both Hepatorenal Syndrome and Non HRS Acute Kidney Injury in Cirrhosis
    Voigt, M.
    Jain, A.
    Lawrence, H.
    TRANSPLANTATION, 2014, 98 : 181 - 181
  • [24] Treatment With Albumin, Octreotide and Midodrine Is Effective as a Bridge to Liver Transplant in Both Hepatorenal Syndrome and Non HRS Acute Kidney Injury in Cirrhosis
    Voigt, M.
    Jain, A.
    Lawrence, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 181 - 181
  • [25] Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients
    Kaffy, F
    Borderie, C
    Chagneau, C
    Ripault, MP
    Larzillière, I
    Silvain, C
    Beauchant, M
    JOURNAL OF HEPATOLOGY, 1999, 30 (01) : 174 - 174
  • [26] MIDODRINE AS A SECONDARY PROPHYLAXIS FOR HEPATORENAL SYNDROME
    Parikh, Pathik
    GUT, 2021, 70 : A68 - A68
  • [27] Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial
    Mahmoud, Eman Ibrahim El-Desoki
    Abdelaziz, Doaa H.
    Abd-Elsalam, Sherief
    Mansour, Noha O.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome
    Eric Esrailian
    Eugene R. Pantangco
    Namgyal L. Kyulo
    Ke-Qin Hu
    Bruce A. Runyon
    Digestive Diseases and Sciences, 2007, 52 : 742 - 748
  • [29] HEPATOPULMONARY SYNDROME RESOLUTION WITH OCTREOTIDE AND MIDODRINE
    Brittan, Mollie
    Wichman, Tammy
    CHEST, 2018, 154 (04) : 923A - 923A
  • [30] Effect of octreotide on hepatorenal syndrome in cirrhotic patients.
    Kaffy, F
    Borderie, C
    Chagneau, C
    Ripault, MP
    Larzilliere, I
    Silvain, C
    Beauchant, M
    HEPATOLOGY, 1997, 26 (04) : 634 - 634
12345